CRISIL Limited traded mildly negative on October 18, 2025, closing near ₹4,695 after slipping about 0.7% intraday from an open around ₹4,770. The day’s range was between ₹4,694 and ₹4,781, maintaining consolidation below its recent resistance zone near ₹4,800. The stock’s 52-week range stands between ₹3,894 and ₹6,955, showing it remains in a mid-range retracement from its highs earlier in the year.
The current trailing 12-month EPS is approximately ₹99.3, giving a P/E ratio near 47, which aligns with its longer-term valuation band. The 50-day moving average (~₹4,965) and 200-day MA (~₹5,115) remain above current levels, indicating medium-term bearish momentum. Volumes were subdued, suggesting a lack of strong directional conviction.
Overall, CRISIL’s short-term trend is sideways-to-weak, facing resistance around ₹4,780–₹4,820 and finding interim support near ₹4,670 followed by ₹4,600. Sustained closes above ₹4,820 could revive buying momentum, while a break below ₹4,600 may invite further correction toward ₹4,450. The technical bias remains neutral until there’s a decisive move outside this consolidation band.
The current trailing 12-month EPS is approximately ₹99.3, giving a P/E ratio near 47, which aligns with its longer-term valuation band. The 50-day moving average (~₹4,965) and 200-day MA (~₹5,115) remain above current levels, indicating medium-term bearish momentum. Volumes were subdued, suggesting a lack of strong directional conviction.
Overall, CRISIL’s short-term trend is sideways-to-weak, facing resistance around ₹4,780–₹4,820 and finding interim support near ₹4,670 followed by ₹4,600. Sustained closes above ₹4,820 could revive buying momentum, while a break below ₹4,600 may invite further correction toward ₹4,450. The technical bias remains neutral until there’s a decisive move outside this consolidation band.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.